NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• NDFIP1 is a known tumor suppressor, but its role in non-small cell lung cancer (NSCLC) is unclear.
• NDFIP1 interacts with WW domain-containing proteins, facilitating their exosome loading.
• The function of WWTR1 (TAZ) in NSCLC and its regulation by NDFIP1 via exosomes remain uninvestigated.

Purpose of the Study:

• To investigate the role of NDFIP1 in NSCLC.
• To elucidate the mechanism by which NDFIP1 regulates the oncogenic protein TAZ.
• To determine if NDFIP1-mediated TAZ exosome secretion affects tumor development.

Main Methods:

• Quantitative analysis of NDFIP1 expression in NSCLC samples and cell lines.
• Co-immunoprecipitation to confirm TAZ-NDFIP1 interaction.
• Exosome isolation and analysis of TAZ presence.
• CRISPR-Cas9 knockout of NDFIP1.
• In vitro and in vivo proliferation assays.
• Western blotting to assess protein levels and degradation.
• Correlation analysis in xenograft models and clinical samples.

Main Results:

• NDFIP1 expression is downregulated in NSCLC and correlates with shorter overall survival (OS).
• NDFIP1 interacts with TAZ, and NDFIP1 is required for TAZ packaging into exosomes.
• NDFIP1 knockout causes TAZ accumulation without affecting mRNA levels or degradation rate.
• Exosome secretion influences cellular TAZ levels.
• NDFIP1 inhibits NSCLC proliferation in vitro and in vivo.
• Silencing TAZ rescues the proliferation increase caused by NDFIP1 knockout.
• TAZ is negatively correlated with NDFIP1 in tumors, and serum exosomal TAZ is lower in NSCLC patients.

Conclusions:

• NDFIP1 functions as a tumor suppressor in NSCLC.
• NDFIP1 regulates TAZ stability and promotes its secretion via exosomes.
• This NDFIP1-mediated exosome pathway represents a novel regulatory mechanism for TAZ in NSCLC progression.